Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
The European Journal of Neuroscience|April 20, 2004
In vivo effects of insulin-like growth factor-I (IGF-I) on prenatal and early postnatal development of the central nervous systemGregory J Popken, Rebecca D Hodge, Ping Ye, et al.Journal of Diabetes Research|November 13, 2014
Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic ratsLaura A Maile, Katherine Gollahon, Christine Wai, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2002
Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic miceHeather R Wilkins, Kinuko Ohneda, Temitope O Keku, et al.Journal of Neuroscience Research|April 23, 2005
Insulin-like growth factor-I protects granule neurons from apoptosis and improves ataxia in weaver miceJin Zhong, Jixian Deng, Jennifer Phan, et al.International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 20, 2007
A non-transformed oligodendrocyte precursor cell line, OL-1, facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte developmentWilliam H Lagarde, Robert Benjamin, Ann T Heerens, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 14, 2008
IGF-I improved bone mineral density and body composition of weaver mutant miceWeiguo Yao, Jin Zhong, Jun Yu, et al.Frontiers in Endocrinology|January 9, 2023
Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.Frontiers in Endocrinology|March 20, 2023
Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparationMartin Bidlingmaier, Beverly M K Biller, David Clemmons, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 19, 2011
Insulin-like growth factor-binding protein-2 is required for osteoclast differentiationVictoria E DeMambro, Laura Maile, Christine Wai, et al.Endocrinology|March 4, 2006
Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitusPatricia Pennisi, Oksana Gavrilova, Jennifer Setser-Portas, et al.Pageof 6